1. Japan Stocks

  2. •

    Consumer Defensive

  3. •

    Household & Personal Products
Shiseido Company, Limited

Shiseido Company, Limited

4911.T
Shiseido Company, LimitedJP flagTokyo Stock Exchange
2,841.00
JPY
+28.50
- -
1.14TMarket Cap
Shiseido Company, Limited
4911.T
(Tokyo Stock Exchange)

Recent

price

2,841.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
1,685.75
1,714.65
1,702.8
1,913.25
1,950.45
1,912.41
2,129.88
2,516.01
2,741.11
2,833.04
2,305.34
2,528.2
2,671.47
2,435.17
2,478.98
2,428.1
2,470.36
Revenue per Share
32.15
36.47
-36.9
65.65
84.44
58.17
80.41
56.95
153.73
184.18
-29.19
117.43
85.6
54.43
-27.06
-101.83
25.05
Basic EPS, GAAP
113.88
70.01
44.02
155.57
28.34
126.5
-11.46
127.07
-12.78
-90.73
-23.64
97.71
-48.73
83.47
-5.77
163.87
59.25
Free Cash Flow per Basic Share
49.96
49.98
49.99
35.02
20.03
19.33
20.57
22.47
34.9
55.15
49.99
40.02
54.99
104.88
60.01
30.05
60
Dividend per Share
743.58
728.95
643.16
672.75
710.43
586.29
807.84
841.59
960.19
1,091.46
1,002.32
1,093.19
1,149.79
1,112.96
1,054.53
964.03
1,083.31
Book Value per Share
336.98
326.83
383.06
481.99
607.56
631.4
419.65
694.14
758.76
672.61
598.63
1,026.17
1,112.93
1,102.63
919.03
967.14
1,705.68
Tangible Book Value per Share
398
398
398
398
399
399
399
399
399
399
399
399
400
400
400
399
400
Basic Weighted Avg Shares
670,701
682,385
677,727
762,047
777,687
763,058
850,306
1,005,062
1,094,825
1,131,547
920,888
1,009,966
1,067,355
973,038
990,586
969,992
987,385
Sales/Revenue/Turnover
6.63
5.74
3.84
6.51
3.55
4.94
4.33
8
9.9
10.06
1.62
9.96
4.36
2.89
0.76
-2.97
1.19
Operating Margin (%)
34,714
36,201
37,537
38,189
38,079
36,933
39,396
43,849
43,845
58,410
67,448
76,058
75,718
75,492
75,666
71,735
76,601
Depreciation Expense
12,790
14,515
-14,685
26,149
33,668
23,210
32,101
22,749
61,403
73,562
-11,660
46,909
34,202
21,749
-10,813
-40,680
10,011
Net Income, GAAP
46.45
56.2
- -
43.01
26.12
40.32
31.97
34.24
37.78
28.01
- -
50.11
25.47
22.1
- -
- -
39.75
Effective Tax Rate (%)
1.91
2.13
-2.17
3.43
4.33
3.04
3.78
2.26
5.61
6.5
-1.27
4.64
3.2
2.24
-1.09
-4.19
1.01
Profit Margin (%)
153,539
150,510
145,456
152,805
149,688
203,889
185,216
234,866
143,054
68,350
124,995
99,361
134,667
101,669
79,238
126,525
61,960
Working Capital
181,155
175,417
145,273
91,863
31,281
67,616
104,022
70,801
60,574
103,159
354,635
264,824
247,441
209,065
234,937
272,954
190,936
LT Debt
320,127
303,715
303,153
358,707
409,369
413,334
413,870
445,872
468,462
517,857
491,310
562,179
625,753
640,392
654,643
621,269
681,747
Total Equity
4.25
3.34
- -
5.5
3.83
4.33
4.79
9.68
12.07
12.21
- -
5.4
3.77
2.36
- -
- -
0.73
Return on Invested Capital (%)
2.15
2.57
- -
5.46
7.49
5.66
7.72
4.81
12.92
12.24
- -
5.68
4.35
3.31
- -
- -
1.43
Return on Capital (%)
4.13
4.95
-5.38
9.98
12.22
8.98
11.54
6.91
17.06
17.95
-2.79
11.21
7.63
4.81
-2.5
-10.09
2.29
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'23
Mar'24
Jun'24
ST Debt
71,916
151,598
124,246
LT Borrowings
110,559
90,595
90,633
LT Finance Leases
98,506
99,668
100,303
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
400
400
400
Market Capitalization
1,699,111
1,635,827
1,833,788

Working Capital

FRC

•

in mil. unless spec.
Dec'23
Mar'24
Jun'24
Total Current Assets
470,014
478,202
482,231
Cash, Cash Equivalents & STI
126,641
113,743
116,439
Accounts Receivable, Net
149,688
166,324
155,117
Inventories
149,646
157,177
167,264
Total Current Liabilities
368,345
449,517
420,271
Payables & Accruals
- -
- -
- -
ST Debt
71,916
151,598
124,246
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.35%
5.04%
-5.1%
Free Cash Flow
-487.34%
-796.3%
-2,940.09%
Net Income, GAAP
-35.63%
-87.86%
276.21%
Sales/Revenue/Turnover
2.95%
1.25%
-2.08%
Total Cash Common Dividend
13.53%
3.11%
-49.94%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
249,453
259,083
- -
- -
990,586
2025
- -
- -
- -
- -
969,992
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-8.22
8.26
- -
- -
-27.06
2025
- -
- -
- -
- -
-101.83
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
28.91
1.07
- -
- -
60.01
2025
- -
- -
- -
- -
30.05
2026
- -
- -
- -
- -
- -
Similar Companies
Green Bridge Industries, Inc. (GRBG)
McPherson's Limited (MCP.AX)
Hindustan Unilever Limited (HINDUNILVR.BO)
Oliveda International, Inc. (OLVI)
Essity AB Class B (ETTYF)
Société BIC S.A. (BB.PA)
Business
Shiseido Company, Limited (4911.T) manufactures and markets a broad portfolio of prestige beauty products, including skincare, makeup, fragrance, and suncare items; its core offerings encompass high-end brands such as SHISEIDO, Clé de Peau Beauté, NARS, IPSA, and Drunk Elephant, sold primarily through beauty consultants at department stores and specialty retailers; mid-priced self-select cosmetics like ELIXIR, ANESSA, AUPRES, and HAKU, available at drugstores and mass merchandisers; professional hair care and color products; life quality makeup under Perfect Cover for consumers with skin challenges; inner beauty supplements via SHISEIDO BEAUTY WELLNESS; and luxury fragrances in partnership with designers including ISSEY MIYAKE PARFUMS, narciso rodriguez, Serge Lutens, and Tory Burch Beauty. Founded in 1872 as Japan's first Western-style pharmacy in Ginza, Tokyo, the company maintains global headquarters at 7-5-5 Ginza, Chuo-ku, Tokyo, and operates in approximately 120 countries and regions across Japan, China, Asia Pacific, Americas, EMEA, and Travel Retail, with major production sites in Japan including Kakegawa, Osaka, and Fukuoka factories. Recent developments include the completion of Shiseido Americas' acquisition of Dr. Dennis Gross Skincare in 2024 to bolster its Americas portfolio and skin beauty focus; strategic partnerships such as with CHITOSE Group for algae-based de-fossil raw materials and JAXA for water-independent skincare; the launch of its 2030 Medium-Term Strategy emphasizing prestige brands, wellness expansion, and life stage solutions; and an absorption-type merger of wholly-owned subsidiary ETWAS Co., Ltd. announced in May 2025.